BioSpace News Archive

Apoptosis Assay Market in 2021 - Detailed Analysis Report with Accurate Forecast

In simple words, apoptosis assays refers to programmed cell deaths, which are able to regulate genetically cell ablation over the period of normal development.

June 10, 2021
·
4 min read
Business

Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors

Corcept Therapeutics Incorporated announced today that Joshua M. Murray has joined the company’s Board of Directors.

June 10, 2021
·
2 min read
Genetown

Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference

Kaleido Biosciences, Inc. today announced that CEO Dan Menichella will deliver a corporate presentation at the JMP Securities Life Sciences Conference at 4PM ET on Thursday, June 17.

June 10, 2021
·
1 min read
Pharm Country

Ocugen to pursue a BLA path in the US for its COVID-19 vaccine candidate

Ocugen, Inc. today announced that upon recommendation from the U.S. Food and Drug Administration (FDA), it will pursue submission of a biologics license application (BLA) for its COVID-19 vaccine candidate, COVAXIN™.

June 10, 2021
·
7 min read
Biotech Bay

Accuray Expands Commercialization of ClearRT™ Helical Fan-Beam kVCT Imaging for the Radixact® System with CE Mark Certification

Expands Global Access to Exceptional Quality Diagnostic-like CT Images for Medical Care Teams Using the Radixact System.

June 10, 2021
·
4 min read
Drug Development

Soligenix Receives Pediatric Investigational Plan Waiver for HyBryte™ in CTCL from the European Medicines Agency

Soligenix, Inc. announced today that it has received a Pediatric Investigation Plan (PIP) waiver from the European Medicines Agency (EMA).

June 10, 2021
·
12 min read
Biotech Bay

Catalyst Biosciences to Participate in Two Upcoming Investor Conferences - June 10, 2021

Catalyst Biosciences, Inc. announced that members of its executive management team will participate in fireside chats at the two investor conferences in June: Raymond James Human Health Innovation Conference and the JMP Securities Life Sciences Conference.

June 10, 2021
·
2 min read
Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference

Viridian Therapeutics, Inc. (Nasdaq: VRDN), today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer of Viridian, will participate in a fireside chat at the virtual JMP Securities Life Sciences Conference

June 10, 2021
·
1 min read
Business

Protara Therapeutics Announces Appointment of Jane Huang, M.D. to Board of Directors

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the appointment of Jane Huang, M.D. to its Board of Directors.

June 10, 2021
·
4 min read
Business

New Spatial Omics Partnership Aims to Accelerate Understanding of Complex Disease Biology

Veranome Biosystems LLC and Portal Bioscience LLC today announced the companies have entered into a co-development agreement to develop cutting-edge products that overcome the analytical challenges posed by the varying levels of RNA degradation often found in clinical specimens.

June 10, 2021
·
3 min read